Green Alpha Advisors, LLC Bluebird Bio, Inc. Transaction History

Green Alpha Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$2.94 - $5.23 $43,100 - $76,671	-14,660 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$4.07 - $10.6 $7,212 - $18,783	1,772 Added 13.75%	14,660 $71,000
Q4 2021 Jan 12, 2022	BUY	$8.96 - $16.31 $2,813 - $5,121	314 Added 2.5%	12,888 $129,000
Q3 2021 Oct 12, 2021	BUY	$11.24 - $21.0 $38,564 - $72,051	3,431 Added 37.53%	12,574 $240,000
Q2 2021 Jul 22, 2021	BUY	$18.04 - $22.09 $31,894 - $39,055	1,768 Added 23.97%	9,143 $292,000
Q1 2021 Jul 22, 2021	BUY	$16.59 - $33.89 $122,351 - $249,938	7,375 New	7,375 $222,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Green Alpha Advisors, LLC with notifications on news.